Thrivent Financial for Lutherans
ACOR

Thrivent Financial for Lutherans’s Acorda Therapeutics, Inc. ACOR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-40,253
Closed -$38K 2312
2020
Q1
$38K Buy
40,253
+2,009
+5% +$1.9K ﹤0.01% 2247
2019
Q4
$78K Buy
38,244
+43
+0.1% +$88 ﹤0.01% 2203
2019
Q3
$110K Buy
38,201
+7,185
+23% +$20.7K ﹤0.01% 2175
2019
Q2
$238K Buy
31,016
+855
+3% +$6.56K ﹤0.01% 2096
2019
Q1
$401K Buy
30,161
+2,709
+10% +$36K ﹤0.01% 1896
2018
Q4
$428K Buy
27,452
+603
+2% +$9.4K ﹤0.01% 1659
2018
Q3
$528K Sell
26,849
-5,438
-17% -$107K ﹤0.01% 1660
2018
Q2
$927K Sell
32,287
-8,695
-21% -$250K ﹤0.01% 1302
2018
Q1
$969K Buy
40,982
+11,858
+41% +$280K ﹤0.01% 1252
2017
Q4
$625K Buy
29,124
+574
+2% +$12.3K ﹤0.01% 1539
2017
Q3
$675K Buy
28,550
+430
+2% +$10.2K ﹤0.01% 1395
2017
Q2
$554K Buy
28,120
+2,220
+9% +$43.7K ﹤0.01% 1461
2017
Q1
$544K Buy
25,900
+1,130
+5% +$23.7K ﹤0.01% 1482
2016
Q4
$466K Buy
24,770
+1,260
+5% +$23.7K ﹤0.01% 1532
2016
Q3
$491K Buy
23,510
+1,100
+5% +$23K ﹤0.01% 1458
2016
Q2
$572K Sell
22,410
-181,450
-89% -$4.63M ﹤0.01% 1358
2016
Q1
$5.39M Sell
203,860
-1,458,450
-88% -$38.6M 0.03% 558
2015
Q4
$71.1M Buy
1,662,310
+29,590
+2% +$1.27M 0.34% 70
2015
Q3
$43.3M Buy
1,632,720
+509,640
+45% +$13.5M 0.23% 112
2015
Q2
$37.4M Buy
1,123,080
+103,060
+10% +$3.43M 0.21% 121
2015
Q1
$33.9M Buy
1,020,020
+15,800
+2% +$526K 0.19% 137
2014
Q4
$41M Buy
1,004,220
+87,410
+10% +$3.57M 0.23% 111
2014
Q3
$31.1M Buy
916,810
+25,450
+3% +$862K 0.18% 135
2014
Q2
$30M Buy
891,360
+260
+0% +$8.77K 0.17% 140
2014
Q1
$33.8M Buy
891,100
+279,600
+46% +$10.6M 0.21% 111
2013
Q4
$17.9M Buy
611,500
+97,300
+19% +$2.84M 0.11% 207
2013
Q3
$17.6M Buy
514,200
+499,400
+3,374% +$17.1M 0.11% 203
2013
Q2
$488 Buy
+14,800
New +$488 ﹤0.01% 937